Smoking cessation duration and risk of Alzheimer’s disease: a nationwide cohort study in Korea

Alzheimer’s Research & Therapy · Published 2026-06-29 · DOI 10.1186/s13195-026-02132-2

Free full text

Authors (3)

Seong-Ho Moon, Min-Ho Kim, Jae-Hong Ryoo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Moon, S., Kim, M., Ryoo, J. (2026). Smoking cessation duration and risk of Alzheimer’s disease: a nationwide cohort study in Korea. Alzheimer’s Research & Therapy. https://doi.org/10.1186/s13195-026-02132-2

Related articles

• Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer’s disease: insights from the ADMET 2 trial · Alzheimer’s Research & Therapy · 2026 · Same journal
• Neural changes after computerized cognitive training in coronary heart disease with mild cognitive impairment: secondary analysis of a randomized clinical trial · Alzheimer’s Research & Therapy · 2026 · Same journal
• Clarifying comparative claims in digital cognitive assessment: a matters arising on multimodal detection of cognitive impairment and amyloid positivity · Alzheimer’s Research & Therapy · 2026 · Same journal
• Sequential associations of myelin dysfunction with Aβ and Tau pathology in Alzheimer's disease: a dynamic myelin perturbation · Alzheimer’s Research & Therapy · 2026 · Same journal
• Resting-state functional dynamics alterations relate to plasma amyloid markers and statistically explain memory impairments in the TgF344-AD model of Alzheimer’s disease · Alzheimer’s Research & Therapy · 2026 · Same journal
• Thresholds for meaningful change in Mini-Mental State Examination scores in rare dementias · Alzheimer’s Research & Therapy · 2026 · Same journal
• Plasma ApoE proteotyping for ApoE ε4 stratification in the anti-amyloid therapies era · Alzheimer’s Research & Therapy · 2026 · Same journal
• Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer’s disease: randomised, controlled trial · Alzheimer’s Research & Therapy · 2026 · Same journal
• Plasma p-tau as a biomarker for the differential diagnosis of Alzheimer’s disease: a systematic review and meta-analysis · Alzheimer’s Research & Therapy · 2026 · Same journal
• Development and validation of a harmonized memory score for multicenter Alzheimer’s disease and related dementia research · Alzheimer’s Research & Therapy · 2026 · Same journal